-+ 0.00%
-+ 0.00%
-+ 0.00%

GT Biopharma Q4 EPS $(4.84) Down From $(1.66) YoY

Benzinga·03/02/2026 14:28:11
Listen to the news
GT Biopharma (NASDAQ:GTBP) reported quarterly losses of $(4.84) per share. This is a 191.57 percent decrease over losses of $(1.66) per share from the same period last year.